Chronic Disease
Our work in Chronic Disease
-
Seminar Series – Adriana Corredor-Waldron
Adriana Corredor-Waldron is an economist studying health disparities and mental health in the United States. She is an Assistant Professor of Economics at North Carolina State University.
-
Seminar Series – Lorens Helmchen
Lorens A. Helmchen, PhD, is an Associate Professor of Health Policy and Management in the Milken Institute School of Public Health at The George Washington University.
-
Changes in HIV Pre-exposure Prophylaxis (PrEP) Coverage at State and County Level During the COVID-19 Pandemic in the United States
Weekly PrEP use declined during the COVID-19 pandemic in 2020, with only 1 in 12 persons at high risk for HIV taking PrEP at least once a week by November 2020 in the U.S.
Categorized in -
Association of Intensive Lifestyle Intervention for Type 2 Diabetes With Labor Market Outcomes
Better chronic disease management through lifestyle modification can improve labor market outcomes among older adults with type 2 diabetes.
Categorized in -
Intensive Lifestyle Counseling and Education by Health Specialists Associated With Higher Employment Rate Among People With Type 2 Diabetes
USC Schaeffer Center research finds intensive lifestyle intervention for people with type 2 diabetes – including weekly counseling on diet and exercise – is associated with increased employment. Researchers say the results suggest the potential of better chronic disease management for improving long-term labor market outcomes.
Categorized in -
Congress Can Eradicate Hepatitis C and Reduce the Deficit at the Same Time
The initiative comes with a $12.3 billion price tag — and over 10 years, the savings in health care costs will reach $18.1 billion.
Categorized in -
Blood Pressure Medication and Dementia Prevention: The Promising Link
SC Schaeffer Center researchers have turned to real-world data to probe the relationship between antihypertensive use and dementia risk in the U.S. population and among minoritized populations who are at the highest risk of dementia.
Categorized in -
Alternatives to the QALY for Comparative Effectiveness Research
We now have useful and valid alternatives that allow for the assessment and valuation of treatments that improve population health without discriminating against vulnerable patient populations.
Categorized in -
Projected Health Benefits and Health Care Savings from the United States National Hepatitis C Elimination Initiative
The national hepatitis C elimination initiative would substantially reduce HCV-related morbidity and mortality and would reduce healthcare spending at 10 years and beyond.
Categorized in -
Medicare Coverage of Weight Loss Drugs Could Significantly Reduce Costs
USC Schaeffer white paper finds that increasing access to obesity treatments would help save lives and reduce healthcare costs.
Categorized in